Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
This study is for men and women over 18 years of age who have suspected or known gastroesophageal reflux disease (GERD) or its associated complications, such as Barrett’s esophagus (a precancerous condition), or trouble swallowing due to esophagitis or scarring (stricture), who are undergoing diagnostic evaluation and treatment with Transoral Incisionless Fundoplication (TIF).
The purpose of this registry study is to learn more about which treatments are effective for patients with different types of GERD symptoms. The registry will also collect relevant information about body weight, height, medications, medical history and other medical results.
If an individual agrees to be in this study, we will ask the following things for research purposes:
Compensation for completing the study questionnaires will be provided.
Participation in this study will last up to 5 years.
Detailed eligibility will be reviewed when individual’s contact the study team.